CMS’ Proposed DIR Fee Reform Garners Industry Support

Published on

The following was provided by Drug Store News:

The latest effort from the Centers for Medicare and Medicaid Services is garnering industry attention. CMS on Tuesday unveiled a proposed rule, titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses,” which includes provisions focused on direct and indirect remuneration, or DIR, fee reform. CLICK HERE to read more.

Schedule a Free Demo

Viewing a system demo is the most efficient way to learn how HBS can help your pharmacy. HBS' Business Managers have years of experience and will walk you through the process to understand your business and provide recommendations regarding the best technology suite that fits your needs today, along with the flexibility for future growth.